Analyst Ratings for Repligen Corp. (RGEN)

Updated: 2017-07-27

Shares of Repligen Corp. (NASDAQ:RGEN) have received a consensus rating of Overweight from Wall Street analysts. RGEN had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 4 analysts, 0 issued an overweight rating, 2 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for RGEN by the analysts covering the stock. The most optimistic analyst gave a price target of 50, implying a possible profit of 22.79 percent. The minimum price target given was 40, implying potential capital losses of -1.77 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -11.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.82 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 2 analysts decreased their estimates.

Analysts estimate earnings of RGEN to grow at a rate of 43.7 percent. The PEG ratio of a stock is another value frequently studied by investors. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of RGEN is 2.45.

RGEN has traded between a high of 46.81 and a low of 26.16 over the past year. Currently the stock is 55.66 percent higher than its low, and 13.01 percent lower than its 52-week high. RGEN has a P/E ratio of 107.16. Investors typically compare the P/E ratio to a company's peers in the industry. The RGEN value stock report compares RGEN to some of its peers using value stock charts. The stock has a market capitalization of $1.54 billion. RGEN will post this quarters earnings in days, on 0000-00-00.